Swagel Wootton Eye Institute Now Offers Cutting-Edge iDose® TR for Glaucoma and Ocular Hypertension Patients

At Swagel Wootton Eye Institute, we are proud to announce that we are among the first practices in Arizona’s East Valley to offer the groundbreaking iDose® TR (travoprost intraocular implant) as a new treatment option for glaucoma and ocular hypertension patients. This FDA-approved implant represents a significant advancement in managing eye pressure, providing a more convenient and effective alternative to traditional eye drops.

What is Glaucoma?

Glaucoma is a serious eye condition caused by increased pressure within the eye, which can damage the optic nerve and lead to permanent vision loss if left untreated. While prescription eye drops have long been the standard treatment, they can be challenging to use consistently and may cause uncomfortable side effects. This often leads to poor adherence to treatment, putting patients at risk for disease progression.

How iDose® TR is Changing Glaucoma Treatment

The iDose® TR implant is designed to address these challenges by delivering continuous, long-term drug therapy directly inside the eye. Unlike traditional eye drops, which require daily application, iDose® TR automatically releases medication over time, significantly reducing the need for daily drops.

According to Dr. Loan Ramsey, MD, FACS, Medical Director at Swagel Wootton Eye Institute, “iDose TR offers a new way to manage eye pressure without the hassle of daily eye drops. This implant makes it easier for patients to adhere to their treatment plan, ultimately leading to better outcomes.”

Proven Results and Benefits

Developed by Glaukos, the iDose® TR implant has been shown to be highly effective in reducing eye pressure. Clinical studies reveal that 8 out of 10 patients were able to stop using their prescription eye drops 12 months after receiving the iDose® TR implant. This treatment is especially beneficial for those who struggle with the daily routine of applying eye drops or have uncontrolled glaucoma with topical medications.

Dr. Janice Piece, OD, Clinical Director at Swagel Wootton, emphasizes, “We are committed to offering our patients the most advanced treatment options. iDose TR represents a significant leap forward in glaucoma care, and we are excited to be among the first in the East Valley to provide this innovative solution.”

Understanding the Side Effects

As with any medical treatment, iDose® TR comes with some potential side effects. The most common include increased eye pressure, inflammation of the iris, dry eye, partial loss of vision, eye pain, redness, and reduced clarity of vision. However, these side effects are typically mild and manageable.

Is iDose® TR Right for You?

If you or a loved one are struggling with glaucoma or ocular hypertension and finding it difficult to maintain your treatment regimen with eye drops, the iDose® TR implant might be an ideal solution. At Swagel Wootton Eye Institute, our experienced team is here to help you explore all available options and determine the best course of treatment for your individual needs.

To learn more about iDose® TR and other cutting-edge treatments available at Swagel Wootton Eye Institute, contact us today to schedule a consultation.